In this Issue:
HBV reactivation with rituximab regimens for lymphoma
Long-term results of first salvage with FCR in CLL
Reduced-toxicity conditioning before allogeneic HSCT in myeloid malignancies
CALR mutations in Chinese patients with primary myelofibrosis
Clinical heterogeneity and outcome predictors in primary AIHA
Post-PE syndrome: chronic complications of PE
Cytogenetics and clinical features of paediatric MDS in Japan
PRES in children with haematological malignancies
Blood and marrow transplantation for sickle cell disease
De novo TMA after organ transplantation
Please login below to download this issue (PDF)